InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,192.49
(
0.23%
)
US TECH 100
17,662.80
(
0.30%
)
Dow Jones
38,882.21
(
0.08%
)
Brent Oil
83.33
(
-0.17%
)
Bitcoin
63,570.29
(
0.64%
)
Post# of 251743
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 44
Posts 4533
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 245388

Thursday, 02/09/2023 8:37:56 AM

Thursday, February 09, 2023 8:37:56 AM

Post# of 251743
AZN earnings - stock is up 5%

https://www.astrazeneca.com/content/dam/az/PDF/2022/fy/Full-year-and-Q4-2022-results-announcement.pdf

AZN predicted sales would reach 45B by 2023 when they rejected PFE's bid in 2013. They pretty much hit that goal one year early. Hindsight is 20/20, and I am not sure the buyout would have gone through anyway, but this was one that got away. PFE undervalued AZN's oncology pipeline at the time
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up